Alector Deferred Long Term Liab Over Time
| ALEC Stock | USD 3.96 0.02 0.51% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Alector Performance and Alector Correlation. Alector |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alector. If investors know Alector will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alector listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.86) | Earnings Share (1.71) | Revenue Per Share 0.661 | Quarterly Revenue Growth 0.684 | Return On Assets (0.19) |
The market value of Alector is measured differently than its book value, which is the value of Alector that is recorded on the company's balance sheet. Investors also form their own opinion of Alector's value that differs from its market value or its book value, called intrinsic value, which is Alector's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alector's market value can be influenced by many factors that don't directly affect Alector's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alector's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alector is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alector's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Deferred Long Term Liab Analysis
Compare Alector and related stocks such as Eliem Therapeutics, HCW Biologics, and Scpharmaceuticals Deferred Long Term Liab Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SCPH | 7 K | 7 K | 7 K | 7 K | 7 K | 7 K | 7 K | 151 K | 765 K | 765 K | 7.5 M | 7.5 M | 7.5 M | 8.6 M | 9.1 M |
| MIST | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| MCRB | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 0.0 | 2.1 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | 2.5 M | 1.8 M |
| LUMO | 1.4 M | 1.4 M | 1.4 M | 1.3 M | 1.6 M | 1.6 M | 1.1 M | 7 M | 6.9 M | 6 M | 6 M | 6 M | 6 M | 6.9 M | 4.3 M |
Alector and related stocks such as Eliem Therapeutics, HCW Biologics, and Scpharmaceuticals Deferred Long Term Liab description
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.My Equities
My Current Equities and Potential Positions
| Alector | ALEC |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 3.96
Check out Alector Performance and Alector Correlation. For information on how to trade Alector Stock refer to our How to Trade Alector Stock guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Alector technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.